Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)
Public ClinicalTrials.gov record NCT04897074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm Pivotal Trial to Assess the Efficacy of AKL-T01, a Novel Digital Intervention Designed to Improve Attention, in Adolescents, Aged 13-17 Years Old, Diagnosed With Attention Deficit Hyperactive Disorder (ADHD)
Study identification
- NCT ID
- NCT04897074
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Akili Interactive Labs, Inc.
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- AKL-T01 Device
Device
Eligibility (public fields only)
- Age range
- 13 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2021
- Primary completion
- Aug 31, 2022
- Completion
- Aug 31, 2022
- Last update posted
- Aug 13, 2023
2021 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melmed Center | Scottsdale | Arizona | 85254 | — |
| Cortica, Inc. | San Diego | California | 92121 | — |
| Accel Research Sites | Maitland | Florida | 32751 | — |
| MTP Psychiatry | Baltimore | Maryland | 21229 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Lincoln Pediatric Group | Lincoln | Nebraska | 68516 | — |
| Alivation Research | Lincoln | Nebraska | 68526 | — |
| Center for Psychiatry and Behavioral Medicine, Inc. | Las Vegas | Nevada | 89128 | — |
| Albuquerque Neuroscience, Inc. | Albuquerque | New Mexico | 87109 | — |
| MindPath Care Centers | Raleigh | North Carolina | 27606 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45206 | — |
| Dayton Clinical Research | Dayton | Ohio | 45409 | — |
| IPS Research | Oklahoma City | Oklahoma | 73106 | — |
| Southeast Houston Research, Inc. | Houston | Texas | 77089 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04897074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04897074 live on ClinicalTrials.gov.